Health Products

ARCHITECT I SYSTEM - ESTRADIOL ASSAY (2016-03-30)

· Published by Health Canada · Official notice

Details

Alert type: Medical Device Recall
Category: Medical Device
Issue: Medical Devices
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameModel or catalog number
More than 10 numbers, contact manufacturer.
Manufacturer
ABBOTT IRELAND DIAGNOSTICS DIVISION
LISNAMUCK, LONGFORD
IRELAND
A. ARCHITECT I SYSTEM - ESTRADIOL ASSAY7K72-20

Introduction

Affected products

A. ARCHITECT I SYSTEM - ESTRADIOL ASSAY

Reason

Reason for the recall is a false increase of estradiol levels in patients treated with Fulvestrant Faslodex) and tested with the ARCHITECT Estradiol assay, list number (LN) 7K72. Nature of defectiveness is the interaction of Fulvestrant with the ARCHITECT Estradiol assay, leading to falsely elevated estradiol results in patients treated with Fulvestrant.
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime